ASCO GI 2022 Highlights: Host-Related Biomarkers Including Gut Microbiome to Predict Toxicities of Nivolumab in Advanced Gastric Cancer - DELIVER Trial (JACCRO GC-08)

191 views
January 26, 2022
Comments 0
Login to view comments. Click here to Login